- with readers working within the Pharmaceuticals & BioTech industries
- within Compliance, Tax and Intellectual Property topic(s)
Could a clinical relationship on LinkedIn trigger consumer protection concerns? In its latest decision, the National Advertising Division weighed in on two LinkedIn posts by Agendia featuring Dr. Nathalie Johnson—who praised Agendia's genomic test over a competitor's—without disclosing her material connections to the company via co-authored research and her role as principal investigator in a study. The NAD recommended that Agendia make those connections “clearly and conspicuously” obvious to audiences.
Hosted by Simone Roach. Based on a blog post by Gonzalo E. Mon.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.